GSA Capital Partners »

4d Molecular Therapeutics In shares owned by GSA Capital Partners

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by GSA Capital Partners from 13F filings

Historical chart of GSA Capital Partners investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by GSA Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by GSA Capital Partners

Quarter filed Position value Share count Share price at filing
2024-09-30 $407k 38k 10.81
2024-06-30 $1.4M 65k 20.99
2022-09-30 $193k 24k 8.04